Evidence map›Paper›PMID 34211543›Full record

ReviewJornal vascular brasileiro2021

Limb ischemia in patients with COVID-19.

Julio Cesar Peclat de Oliveira, Walter Jr Boim Araujo, Sergio Quilici Belczak, Fabiano Luiz Erzinger, Lucas Maia Peclat de Oliveira, Marcos Arêas Marques, Lucas Mansano Sarquis, Bianca Gutfilen

Open access · diamondAbstract readReview
In one paragraph

Review in Jornal vascular brasileiro, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. COVID-19 and limb ischemia.Visual journal of emergency medicine · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Julio Cesar Peclat de OliveiraUniversidade Federal do Rio de Janeiro - UFRJ, Rio de Janeiro, RJ, Brasil.ORCID 0000-0003-1504-8763
Walter Jr Boim AraujoUniversidade Federal do Paraná - UFPR, Curitiba, PR, Brasil.ORCID 0000-0003-1537-0285
Sergio Quilici BelczakInstituto de Aprimoramento e Pesquisa em Angiorradiologia e Cirurgia Endovascular - IAPACE, São Paulo, SP, Brasil.
Fabiano Luiz ErzingerHospital Erasto Gaertner, Curitiba, PR, Brasil.ORCID 0000-0002-6650-1145
Lucas Maia Peclat de OliveiraUniversidade Federal do Estado do Rio de Janeiro - UNIRIO, Rio de Janeiro, RJ, Brasil.ORCID 0000-0002-5454-3129
Marcos Arêas MarquesUniversidade Federal do Estado do Rio de Janeiro - UNIRIO, Rio de Janeiro, RJ, Brasil.
Lucas Mansano SarquisHospital do Trabalhador, Curitiba, PR, Brasil.ORCID 0000-0001-9703-1732
Bianca GutfilenUniversidade Federal do Rio de Janeiro - UFRJ, Rio de Janeiro, RJ, Brasil.ORCID 0000-0001-8632-7474
Universidade Federal do Rio de Janeiro · BRBrazilian Agricultural Research Corporation · BRGaertner (United States) · USUniversidade do Estado do Rio de Janeiro · BRUniversidade Federal do Estado do Rio de Janeiro · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This narrative review covers the life-threatening thromboembolic events associated with SARS-CoV-2 infection/COVID-19. It addresses the physical changes that cause vascular and arterial damage to limbs, laboratory management of coagulation, and management of anticoagulation. COVID-19's relationship with deep venous thrombosis and arterial thrombosis is also emphasized. The main thromboembolic events described in the literature are illustrated with examples from our experience with COVID-19 patients.

Indexed as

anticoagulantsCOVID-19embolisms and thrombosisendovascular techniquesSARS-CoV-2vascular diseases

Identifiers

PMID34211543
PMCPMC8218822
OpenAlexW3169110882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.